Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)
Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%
Lifevantage total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Lifevantage's total debt was $0 at Jun 30, 2020. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $29.77M in fiscal 2014.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Jun 30, 2020 | $0 | -100.0% |
| FY2019 | Jun 30, 2019 | $1.45M | -73.1% |
| FY2018 | Jun 30, 2018 | $5.41M | -27.3% |
| FY2017 | Jun 30, 2017 | $7.44M | -20.9% |
| FY2016 | Jun 30, 2016 | $9.41M | -52.2% |
| FY2015 | Jun 30, 2015 | $19.67M | -33.9% |
| FY2014 | Jun 30, 2014 | $29.77M | – |
| FY2013 | Jun 30, 2013 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $0 | -100.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $0 | -100.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $484.00K | -89.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $969.00K | -80.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $1.45M | -73.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.94M | -67.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $4.43M | -31.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $4.92M | -29.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $5.41M | -27.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $5.97M | -24.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $6.46M | -23.3% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $6.95M | -22.1% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $7.44M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $7.93M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $8.42M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $8.92M | – |
See a number that looks wrong?